| Статус: | Completed |
| Фаза: | не указано |
| Начало: | 16 октября 2017 г. |
| Окончание: | 22 декабря 2017 г. |
| Описание: | Study the efficacy and safety of therapy for threatened miscarriage with medicinal products Utrogestan (micronized progesterone), 200 mg capsules (Besins Healthcare SA, Belgium), and Duphaston (Dydrogesterone), 10 mg coated tablets (Abbott Healthcare Products B.V., the Netherlands) |
| смотреть на ClinicalTrials.gov |